Cafepharma Today

October 17 2024 - Sage lays off half of R&D team, shakes up C-suite again
Sage lays off half of R&D team, shakes up C-suite again
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Merck Profit Falls, Misses Expectations
CNBC
Tuesday, April 21, 2009 - 7:44am
tags:
Merck, earnings
Merck to license infection drug for up to $225 million
Marketwatch
Tuesday, April 21, 2009 - 6:53am
tags:
Merck, anti-infectives, licensing, Medarex
Schering-Plough profit jumps on Organon accounting changes
Marketwatch
Tuesday, April 21, 2009 - 6:52am
tags:
Schering Plough, earnings
FDA, Clinical Trial Calendar Updates: Discovery, Impax Labs
Seeking Alpha
Tuesday, April 21, 2009 - 6:33am
tags:
Impax Labs, FDA, drug trials, Discovery Labs, Surfaxin
Icahn Has a Match in Mind for Amylin. Well, Maybe
WSJ Online
Monday, April 20, 2009 - 5:20pm
tags:
Amylin, Carl Icahn, Eli Lilly
Drug stocks flee into negative territory
Marketwatch
Monday, April 20, 2009 - 4:32pm
tags:
drug stocks
A Cheer and a Boo for Eli Lilly
Motley Fool
Monday, April 20, 2009 - 4:29pm
tags:
Eli Lilly, earnings, patents
Report: Pharma deals in 1Q exceed all 2008 deals
Yahoo/AP
Monday, April 20, 2009 - 4:29pm
tags:
pharma industry, M&A
Earnings Preview: Merck
Seeking Alpha
Monday, April 20, 2009 - 4:28pm
tags:
Merck, earnings
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Pharmaceutical Business Review
Monday, April 20, 2009 - 10:56am
tags:
Vion Pharmaceuticals, Onrigin, FDA, leukemia
Biogen's Tysabri Reports 6th Case
Yahoo/Zacks.com
Monday, April 20, 2009 - 10:53am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis, PML
Galapagos signs Merck deal, shares leap
Reuters
Monday, April 20, 2009 - 10:40am
tags:
Galapagos, Merck
More FDA frustration for Discovery Labs
Bizjournals.com
Monday, April 20, 2009 - 10:39am
tags:
FDA, Discovery Labs, Surfaxin
Gilead Preview: HIV Drugs Still Focus
TheStreet.com
Monday, April 20, 2009 - 10:38am
tags:
Gilead Sciences, HIV, CV Therapeutics
Drug stocks, broad market slide on economic fears
Marketwatch
Monday, April 20, 2009 - 10:37am
tags:
drug stocks
Glaxo’s Stiefel Buy: No Blockbusters, Please
WSJ Online
Monday, April 20, 2009 - 10:36am
tags:
GSK, buyouts, Stiefel Labs
Pharmasset ends development of lead drug candidate over concerns for hepatitis B patients
Yahoo/AP
Monday, April 20, 2009 - 8:37am
tags:
Pharmasset, hepatitis B, clevudine
Cipla Declines on Report FDA Finds Production Flaws
Bloomberg
Monday, April 20, 2009 - 8:36am
tags:
Cipla, India, FDA
Pounce on Abbott While It's Down
Yahoo/Real Money
Monday, April 20, 2009 - 8:34am
tags:
Abbott Laboratories, GSK, JNJ
Eli Lilly Earnings Top Estimates, Sales Up 5%
TheStreet.com
Monday, April 20, 2009 - 8:34am
tags:
Eli Lilly, earnings

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline
Induced Proximity, in the Lab and in the Clinic
In the Pipeline
If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?
Drug Channels
Half-Full and Half-Empty AI Glasses
In the Pipeline
As MFP Approaches, Transparency Is More Important Than Ever
Drug Channels
Long, Slow Stories
In the Pipeline
Coronavirus Vaccination: Room for Improvement
In the Pipeline
Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
Drug Channels
The 2024 Chemistry Nobel: Computational Protein Design
In the Pipeline

Latest Jobs

Virtual Lead Generation & Sales Specialist - Pharmaceuticals
Jacksonville, Florida, 32290
Syneos Health/ inVentiv Health Commercial LLC
Neuroscience Account Manager (Psychiatry) - Pensacola, FL
Pensacola, Florida, 32573
Vanda Pharmaceuticals
Structural Heart/ICE Territory Sales Manager, Northwest
Issaquah, Washington, 98027
Siemens Medical Solutions USA, Inc
Sales Executive
Everett, Washington, 98213
Abel Consulting
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Territory Account Manager
Orange, California, 92613
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement, CNS - Charlottesville, VA
Roanoke, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago W, IL
Chicago, Illinois,
Otsuka
Pharmaceutical Sales Customer Engagement- Corpus Christi, TX
Corpus Christi, Texas,
Otsuka
Hearing Aid Sales Consultant
Barrington, Rhode Island, 02806
Beltone New England
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information